Last reviewed · How we verify

NCT04639089

The Effect of Platelet Rich Pasma on Strenal Healing Post Median Strenotomy in Patients Undergoing Open Heart Surgery

Status unknown NA Last updated 15 February 2022
What this trial tests

NA trial testing platlet rich plasma on sternal healing post median sternotomy in Cardiac Surgical Procedures in 50 participants. Status unknown.

Timeline
14 August 2020
Primary endpoint
30 August 2022
15 December 2023

Quick facts

Lead sponsorDr. Hamdy Singab
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment50
Start date14 August 2020
Primary completion30 August 2022
Estimated completion15 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Hamdy Singab

Who can join

Adults 70 to 90, any sex, with Cardiac Surgical Procedures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Platelet-rich plasma (PRP) is an autologous concentration of human platelets in a small volume of plasma. Because it is an autogenous preparation, PRP is inherently safe and therefore free from concerns over transmissible diseases such as HIV and hepatitis. Its power of regeneration already proved by orthopedics and dentists in their trials to regenerate cartilages .We will use it to know its ability to enhance healing of sternum in vulnerable patients to sternal dehiscence after open heart surgery .

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Interventions to prevent surgical site infection in adults undergoing cardiac surgery.
    Cardiothoracic Interdisciplinary Research Network, Rogers LJ, Vaja R, Bleetman D, et al · · 2024 · cited 2× · PMID 39620424 · DOI 10.1002/14651858.cd013332.pub2

Verify or expand the search:

Other recruiting trials for Cardiac Surgical Procedures

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04639089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing